skip to content

School of the Biological Sciences



Deputy Director, Milner Therapeutics Institute 

Kathryn Chapman's interests are in facilitating academic/industry interactions to accelerate drug development. Learn more. 


Research Areas

Target validation
Functional genomics
Disease signature identification and interrogation


Complex cellular models and assays  
Genetic screening
Live cell imaging

Areas for Collaboration

Drug development
Academic/industry interactions
Artificial Intelligence and machine learning
Target validation
Complex cellular assay development and screening 


Research Theme